Aardvark Therapeutics, Inc. Common Stock (AARD) vs Black Diamond Therapeutics, Inc. (BDTX)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Black Diamond Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.11HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
BDTX
Black Diamond Therapeutics, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — AARD vs BDTX
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)BDTX -14.2% (-7.3%/yr)BDTX compounded faster over this window
AARD BDTX
AARD vs BDTX: by the numbers
- •AARD is the larger company ($112M vs $109M market cap).
- •BDTX is profitable (31.95% net margin) while AARD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AARD | BDTX |
|---|---|---|
| P/B ratio | 1.49 | 1.13 |
Profitability
| Metric | AARD | BDTX |
|---|---|---|
| Gross margin | 0.00% | 99.54% |
| Operating margin | 0.00% | 28.39% |
| Net margin | 0.00% | 31.95% |
| ROE | -93.44% | -44.29% |
| ROIC | -97.99% | -47.54% |
Growth (annualized)
| Metric | AARD | BDTX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -24.47% |
Frequently asked
- Is AARD or BDTX more profitable?
- BDTX runs the higher net margin — AARD at 0.00% versus BDTX at 31.95%.
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROEBlack Diamond Therapeutics ROEAardvark Therapeutics, Inc. Common Stock operating marginBlack Diamond Therapeutics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthBlack Diamond Therapeutics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowBlack Diamond Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.